The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first ...

Merck's Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase.

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian cancer who have received prior treatment, the regulator said on Thursday.

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

The treatment, branded as Emrelis, belongs to a class of drugs known as antibody-drug conjugates, which act as ...

Biosimilars offer high-quality, lower-cost cancer treatments. Learn how they’re helping patients and reshaping global ...

This marks the first and only FDA-approved medicine for low-grade serous ovarian cancer (LGSOC) that tests positive for a gene change known as the KRAS mutation. The treatment includes two drugs ...

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...

Akeso said on Friday it has received approval for treatments with penpulimab-kcqx, which is used in the fight against nasopharyngeal cancer, or NPC. In a separate announcement, the drug co ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...

In June 2024, the FDA approved a new drug application for a ready-to-dilute formulation of Tepylute for the treatment of patients with adenocarcinoma of the breast and ovary. Breast cancer forms in ...